Presence of inflammation at baseline, 4-week and 12-week followup visits. Data are number of patients (%).
| Control | Treatment | Total | p | |
|---|---|---|---|---|
| Baseline | 13/35 (42) | 18/36 (58) | 31/71 (44) | 0.20 |
| 4 weeks | 14/33 (42) | 16/33 (48) | 30/66 (45) | 0.40 |
| 12 weeks | 12/27 (44) | 11/24 (46) | 23/51 (45) | 0.57 |